| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA615646 | F | Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 128 mg/kg (Dose range 256-16) | Mus musculus | 1 | ALA1121486 | organism-based format | Scientific Literature | |
| 2. | ALA615648 | F | Compound tested for toxicity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (6/6) | Mus musculus | 2 | ALA1121486 | organism-based format | Scientific Literature | |
| 3. | ALA615649 | F | Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as animal weight difference of the treated and the control (T-C) at OD of 100 mg/kg | Mus musculus | 3 | ALA1121486 | organism-based format | Scientific Literature | |
| 4. | ALA615650 | F | Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as percentage of cured animals at OD of 100 mg/kg | Mus musculus | 3 | ALA1121486 | organism-based format | Scientific Literature | |
| 5. | ALA708280 | F | Antitumor effect against MAC13 Tumors was determined by the percent of mean weight of treated tumors to mean weight of control tumors by 10% ethanol/arachis oil at dose 20 mg/kg | Mus musculus | 1 | ALA1129536 | organism-based format | Scientific Literature | |
| 6. | ALA708312 | F | Antitumor effect against MAC13 Tumors was determined by no. deaths/treated of mice by 10% ethanol/arachis oil at dose 20 mg/kg; no of deaths/treated 0/5 | Mus musculus | 1 | ALA1129536 | organism-based format | Scientific Literature | |
| 7. | ALA706467 | F | Antitumor effect against MAC15A Tumors was determined by the percent of mean weight of treated tumors to mean weight of control tumors by saline at dose 20 mg/kg | Mus musculus | 1 | ALA1129536 | organism-based format | Scientific Literature | |
| 8. | ALA965582 | B | Inhibition of bovine brain MAOA | Bos taurus | 92 | ALA1152129 | assay format | Scientific Literature | |
| 9. | ALA1614121 | F | PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Activators of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1829 (Project Summary), 1814 (Primary HTS)] | Homo sapiens | 2,121 | ALA1201862 | cell-based format | PubChem BioAssays | |
| 10. | ALA1614458 | F | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | Homo sapiens | 75,376 | ALA1201862 | assay format | PubChem BioAssays | |
| 11. | ALA1613842 | F | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | Homo sapiens | 33,402 | ALA1201862 | assay format | PubChem BioAssays | |
| 12. | ALA1613924 | F | PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Activators of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1829 (Project Summary), 1814 (Primary HTS)] | 1,708 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 13. | ALA1613936 | F | PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Response HTS to Identify Activators of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells. (Class of assay: confirmatory) [Related pubchem assays: 1829 (Project Summary), 1814 (Primary HTS)] | 2,160 | ALA1201862 | cell-based format | PubChem BioAssays | ||
| 14. | ALA1794345 | F | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | Plasmodium falciparum | 170,142 | ALA1201862 | organism-based format | PubChem BioAssays | |
| 15. | ALA1794569 | F | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | 18,965 | ALA1201862 | assay format | PubChem BioAssays | ||
| 16. | ALA1794580 | F | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | Plasmodium falciparum | 130,890 | ALA1201862 | organism-based format | PubChem BioAssays | |
| 17. | ALA1909163 | B | DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4) | Cavia porcellus | 871 | ALA1909046 | tissue-based format | DrugMatrix | |
| 18. | ALA1909164 | B | DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4) | 871 | ALA1909046 | cell membrane format | DrugMatrix | ||
| 19. | ALA1909165 | B | DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid) | Oryctolagus cuniculus | 871 | ALA1909046 | tissue-based format | DrugMatrix | |
| 20. | ALA1909166 | B | DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH) | 871 | ALA1909046 | cell membrane format | DrugMatrix |
The page will load shortly, Thanks for your patience!